Next week, the School of Medicine and Public Health at the University of Wisconsin-Madison will resume enrolling patients for a study that’s been on hold since early September. The study is for a coronavirus vaccine produced by Oxford University and the British pharmaceutical manufacturer AstraZeneca. Thirty-six participants received the first of two shots before the study was paused. Those participants will now have the option to receive their second dose.
Office of Strategic Communication